FTC Seeks More Info On $5.2B Watson, Actavis Merger
By Eric Hornbeck ( July 12, 2012, 11:53 AM EDT) -- Watson Pharmaceuticals Inc. said Thursday that the Federal Trade Commission has asked for further information about its €4.25 billion ($5.2 billion) plan to buy Swiss drugmaker Actavis Group as the agency reviews possible anti-competitive effects of the deal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.